KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 72 filers reported holding KALA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
Matisse Capital | 50,300 | $377,000 | 0.15% |